CPT1A and COVID-19: In another study, CPT1a+VDAC1+HLA-DR− M-MDSC frequencies were found to be significantly higher in severe compared to mild COVID-19 patients [55], and these differences were observed before the respiratory nadir in severe COVID-19 patients [17].